Ryan Ungaro, MD, MS

Icahn School of Medicine at Mount Sinai
New York, NY

Presentation(s):

• 37 - Induction and Maintenance Treatment with Risankizumab Leads to Symptomatic Relief in Patients With Moderate to Severe Crohn’s Disease

  Tuesday, October 25, 2022
  2:15 PM – 2:25 PM ET